279 related articles for article (PubMed ID: 27546351)
41. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
42. Clinical, cytologic, and immunohistochemical features of sarcomas involving body cavity fluids.
Chen AL; Janko E; Pitman MB; Chebib I
Cancer Cytopathol; 2019 Dec; 127(12):778-784. PubMed ID: 31693303
[TBL] [Abstract][Full Text] [Related]
43. Utility of cell block to detect malignancy in fluid cytology: Adjunct or necessity?
Dey S; Nag D; Nandi A; Bandyopadhyay R
J Cancer Res Ther; 2017; 13(3):425-429. PubMed ID: 28862203
[TBL] [Abstract][Full Text] [Related]
44. Comparison of Conventional Cytology, Liquid-Based Cytology, and Cell Block in the Evaluation of Peritoneal Fluid in Gynecology Malignancies.
Amiri Z; Momtahan M; Mokhtari M
Acta Cytol; 2019; 63(1):63-72. PubMed ID: 30625466
[TBL] [Abstract][Full Text] [Related]
45. Chromosome analysis in effusions as a diagnostic adjunct to cytology.
Augustus M; Visveshwara RN; Bhargava MK
Indian J Cancer; 1989 Jun; 26(2):67-75. PubMed ID: 2592000
[TBL] [Abstract][Full Text] [Related]
46. [Clinical values of cytological evaluation of pleural and peritoneal fluids].
Konda C
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1716-20. PubMed ID: 7184369
[TBL] [Abstract][Full Text] [Related]
47. Telomerase activity in benign and malignant cytologic fluids.
Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ
Cancer; 1999 Apr; 87(2):93-9. PubMed ID: 10227600
[TBL] [Abstract][Full Text] [Related]
48. Cytomorphologic features of small cell carcinoma of lung in effusion fluid using a liquid-based cytology technique.
Kim L; Choi SJ; Park IS; Han JY; Kim JM; Chu YC
Diagn Cytopathol; 2020 Mar; 48(3):203-210. PubMed ID: 31820590
[TBL] [Abstract][Full Text] [Related]
49. Performance Characteristics of Body Fluid Cytology Analysis of 344 380 Responses From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology.
Tabatabai ZL; Nayar R; Souers RJ; Crothers BA; Davey DD
Arch Pathol Lab Med; 2018 Jan; 142(1):53-58. PubMed ID: 29048220
[TBL] [Abstract][Full Text] [Related]
50. Cytomorphology, Immunophenotype, and cytogenetic profile of leukemic serous effusions.
Kaur K; Patel T; Patra S; Trivedi P
Diagn Cytopathol; 2021 Aug; 49(8):948-958. PubMed ID: 33973738
[TBL] [Abstract][Full Text] [Related]
51. Cytological evaluation and significance of cell cannibalism in effusions and urine cytology.
Ahmed Wani F; Bhardwaj S
Malays J Pathol; 2015 Dec; 37(3):265-70. PubMed ID: 26712673
[TBL] [Abstract][Full Text] [Related]
52. Cytology and flow cytometry of malignant effusions of multiple myeloma.
Palmer HE; Wilson CS; Bardales RH
Diagn Cytopathol; 2000 Mar; 22(3):147-51. PubMed ID: 10679993
[TBL] [Abstract][Full Text] [Related]
53. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
54. DNA Ploidy Analysis and Cell Block Immunohistochemistry in the Diagnosis of Malignant Effusions.
Puri M; Sen R; Gupta M; Kalra R; Bhargava S; Puri K
Acta Cytol; 2020; 64(3):256-264. PubMed ID: 31466063
[TBL] [Abstract][Full Text] [Related]
55. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
[TBL] [Abstract][Full Text] [Related]
56. MOC31 Immunostaining in the Diagnosis of Metastatic Adenocarcinoma in Serous Fluid: Special Emphasis on Atypical Cytological Cases.
Sahu S; Sharma S; Gupta P; Dey P
Acta Cytol; 2021; 65(3):242-249. PubMed ID: 33827073
[TBL] [Abstract][Full Text] [Related]
57. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
Marsan C; Gaulier A; Sabatier P; Garcia R
Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
[TBL] [Abstract][Full Text] [Related]
58. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides.
Florentine BD; Sanchez B; Raza A; Frankel K; Martin SE; Kovacs B; Felix JC
Cancer; 1997 Oct; 81(5):299-308. PubMed ID: 9349518
[TBL] [Abstract][Full Text] [Related]
59. Pleural, peritoneal and pericardial effusions - a biochemical approach.
Kopcinovic LM; Culej J
Biochem Med (Zagreb); 2014; 24(1):123-37. PubMed ID: 24627721
[TBL] [Abstract][Full Text] [Related]
60. Morphometric differences between cytologically benign and malignant serous effusions.
Gavin FM; Gray C; Sutton J; Clayden AD; Banks RI; Bird CC
Acta Cytol; 1988; 32(2):175-82. PubMed ID: 2450434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
